X-linked severe combined immunodeficiency disease (X-SCID) is a rare genetic disorder characterized by profound defects in ...

X-linked severe combined immunodeficiency disease (X-SCID) is a rare genetic disorder characterized by profound defects in T-cell, B-cell, and natural ...

Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent ...

The team was able to reach protein yields at the pool stage that couldn’t be achieved previously with a random integration approach.

Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on ...

Biopharma companies require optimal clone yields to ensure maximum concentration and effectiveness of these therapeutic ...

Scientists dive into the genomes of whales, elephants, and other animal giants looking for new weapons in the fight against ...

Researchers at Washington University School of Medicine in St. Louis have uncovered why some patients with a rare genetic ...

Johns Hopkins scientists develop mRNA "booster" as potential new way to treat rare genetic diseases marked by too low levels ...

Genetic engineering is the act of modifying the genetic makeup of an organism. Modifications can be generated by methods such as gene targeting, nuclear transplantation, transfection of synthetic ...

Sex differences in the risk factors, diagnosis, treatment, and outcomes of patients with cardiovascular disease have been ...

Peptides designed by artificial intelligence restrict both drug-resistant bacteria and rapidly evolving viruses.